Reading this clinical breakthrough? See how real patients are applying these numbers in real life. See how members lowered A1C, timed Metformin ER, and optimized thyroid labs—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Diabetes, Thyroid & A1C Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Diabetes, Thyroid & A1C Space →
Official NIH NLM MEDLINE / PubMed Citation • PMID: 42967580 • DOI: 10.1002/edm2.70356

Effectiveness of Traditional Chinese Fitness Methods on Depressive Symptoms and Glycaemic Control in Patients With Type 2 Diabetes and Comorbid Depression: A Systematic Review and Meta-Analysis of Taijiquan and Baduanjin.

Endocrinology, diabetes & metabolism • 2026 Nov • Vol. 9 (6) • ISSN 2398-9238
Authors: Xinyue Tian, Yiwen Wei, Jingwen Bo, Keke Lin, Yina Shen, Yu Liu
School of Nursing, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Verbatim Formal Study Abstract

AIMS

To evaluate the overall effectiveness of traditional Chinese fitness methods (TCFMs)-specifically Taijiquan and Baduanjin-on depressive symptoms and glycaemic control in patients with Type 2 diabetes (T2DM) and comorbid depression.

METHODS

RCTs evaluating the effectiveness of TCFMs were identified through 10 major English and Chinese databases, including PubMed, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science, Wiley Online Library, ProQuest, CBM, CNKI, VIP, and Wanfang Data. Risk of bias was assessed using the revised Cochrane RoB 2 tool, and evidence certainty was graded using GRADE. Meta-analyses were conducted using the DerSimonian-Laird random-effects model. Subgroup analyses were performed by intervention duration, frequency, and sample size.

RESULTS

Eight RCTs of Taijiquan and Baduanjin were included. All studies were conducted in China, and most had small sample sizes. Most had a high risk of bias, mainly due to a lack of blinding of participants and personnel. TCFMs were associated with significant improvements in depressive symptoms (SMD&#x2009;=&#x2009;-1.39, 95% CI [-2.22, -0.57], p&#x2009;=&#x2009;0.001). Significant improvements were also observed for HbA1c (MD&#x2009;=&#x2009;-0.82, 95% CI [-1.18, -0.45], p&#x2009;<&#x2009;0.0001) and FPG (MD&#x2009;=&#x2009;-0.70, 95% CI [-0.97, -0.42], p&#x2009;<&#x2009;0.00001). The effect on 2hPBG remains inconclusive owing to limited studies. Subgroup analyses revealed no significant effect modifiers for depressive symptoms or HbA1c (all interaction p&#x2009;>&#x2009;0.05). Sensitivity analyses confirmed the robustness of the primary findings, though heterogeneity decreased substantially after excluding high-risk studies.

CONCLUSIONS

This review provides preliminary evidence that TCFMs may confer benefits on mental health and glycaemic regulation in patients with T2DM and comorbid depression. However, given the low certainty of the evidence, high heterogeneity, and methodological limitations, these findings should be interpreted cautiously. The conclusions are preliminary and require confirmation in larger, rigorously designed studies.

TRIAL REGISTRATION

The protocol of this systematic review was registered on PROSPERO (CRD420261287519).

Publication Classification: Journal Article Meta-Analysis Systematic Review
NLM MeSH Descriptors: Humans Comorbidity Depression Diabetes Mellitus, Type 2 Glycemic Control Medicine, Chinese Traditional Tai Ji